MET increased gene copy number and primary resistance to gefitinib therapy in non-small-cell lung cancer patients.
(Q37321772)
scientific article published on 03 October 2008
scientific article published on 03 October 2008
Language:
Current Data About
MET increased gene copy number and primary resistance to gefitinib therapy in non-small-cell lung cancer patients.